Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

Executive Summary

• Fennec Pharmaceuticals announced it will publish its full‑year and Q4 2025 financial results before the U.S. market opens on Tuesday, March 24, 2026.
• Management will host a conference call and webcast at 8:30 a.m. ET to discuss the results and business outlook.
• The announcement provides investors with advance notice of the upcoming earnings release and access details for the live and archived webcast.

Key Details

• Release Timing: Full‑year and Q4 2025 results will be released before market open on March 24, 2026.
• Conference Call/Webcast:
• Date: Tuesday, March 24, 2026
• Time: 8:30 a.m. Eastern Time
• Live webcast link: https://edge.media-server.com/mmc/p/3crq898e
• Participant registration link: https://register-conf.media‑server.com/register/BIb7d9f04377fd4b9cb7b005d167555402
• Access Instructions: Investors should log onto www.fennecpharma.com, navigate to the News & Events/Event Calendar under Investors & Media, and join at least 15 minutes early to allow for any required software download.
• Replay Availability: The webcast will be archived on the company website for thirty days after the call.

Notable Quotes

(No executive quotes were included in this release.)